openPR Logo
Press release

CNS Specific Antisense Oligonucleotide Market - Market Trends With Value Chain And Stakeholder Analysis Appraised By Global Players Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Wave Life Sciences Ltd.

02-15-2019 08:44 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Global CNS Specific Antisense Oligonucleotide Market

Global CNS Specific Antisense Oligonucleotide Market

Antisense oligonucleotides are synthetic strings of nucleic acid, which reduce expression of messenger RNA (m-RNA). The function performed by interference with pre m- RNA splicing are restoration of protein and modification of protein. Antisense oligonucleotide is a new approach to treat several neurodegenerative disorders to prevent disease onset or stop disease development.

Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/2477

Market Dynamics

Increasing prevalence of neurodegenerative disease is a major factor driving CNS specific antisense oligonucleotide market growth. According to fact sheet from Alzheimer Association, an estimated around 5.7 million Americans were diagnosed with Alzheimer's dementia in 2018. Moreover, rich product pipeline for the treatment of CNS disorders and rare diseases associated with it is expected to boost the market growth. For instance, in December 2018, Biogen and Ionis Pharmaceuticals product IONIS-SOD1Rx (BIIB067) cleared Phase 1 clinical trial and is expected to be launched by 2020.

Increasing Prevalence Of Cancer Is Expected To Propel Growth Of The Cns Specific Antisense Oligonucleotide Market

CNS specific antisense oligonucleotide is used for treatment of neurodegenerative disorders and associated rare diseases. According to February 2017, report of National Center for Biotechnology Information (NCBI), an estimated the prevalence of Cerebral palsy ranges from 1.5 to more than 4 per 1,000 of children from age 10 to 14 years. The birth prevalence of Cerebral palsy is around 2 per 1,000 live births globally.

Furthermore, launch of new products for rare disease associated with CNS disorders is propelling growth of the CNS specific antisense oligonucleotide market over the forecast period. For instance, in October 2018, Ionis Pharmaceuticals, Inc. and Akcea Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) approval for its novel drug TEGSEDITM (inotersen) indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. In the same year, company received approval from Canadian Health authority for the novel drug TEGSEDITM (inotersen).

However, high cost of treatment and risk of toxicity is expected to hinder the market growth. According to the Journal Molecular Therapy, in May 2017, Biogen priced Spinraza (nusinersen injection) at US$ 750,000 for the first year’s treatment (US$125,000 per injection) and US$350,000 per year.

Key Players

Major players operating in the global CNS specific antisense oligonucleotide market include Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Wave Life Sciences Ltd., Stroke Therapeutic Inc., Dynacure, ProQR Therapeutics N.V., and Q-STATE BIOSCIENCES, INC.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2477

Detailed Segmentation:

Global CNS Specific Antisense Oligonucleotide Market, By Drug:
Approved
Patisiran
Nusinersen
Inotersen
Pipeline
IONIS-HTT Rx (RG6042)

Global CNS Specific Antisense Oligonucleotide Market, By Indication:
Hereditary transthyretin amyloidosis (hATTR)/ Polyneuropathy
Spinal Muscular Atrophy
Huntington’s Disease

Global CNS Specific Antisense Oligonucleotide Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Global CNS Specific Antisense Oligonucleotide Market, By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa

Browse Research Report At: https://www.coherentmarketinsights.com/market-insight/cns-specific-antisense-oligonucleotide-market-2477

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CNS Specific Antisense Oligonucleotide Market - Market Trends With Value Chain And Stakeholder Analysis Appraised By Global Players Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Wave Life Sciences Ltd. here

News-ID: 1591143 • Views:

More Releases from Coherent Market Insights

High End Greenhouse Market Exploration 2024 to 2031: Innovations, Key Players Data and Upcoming Opportunities |Texas Greenhouse Company Inc., Nexus Corporation
High End Greenhouse Market Exploration 2024 to 2031: Innovations, Key Players Da …
The global high end greenhouse market is estimated to surpass US$ 3,025.1 million by the end of 2030 in terms of revenue, exhibiting a CAGR of 5.2% during the forecast period (2023 to 2030). New Research Study High End Greenhouse Market 2024 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook has been added to Coherent Market insight The High End Greenhouse Market research
Tattoo Accessories Market Insights Discussed Regarding Size, Share & Growth Opportunity | Major companies operating in the global tattoo accessories market are: Cheyenne
Tattoo Accessories Market Insights Discussed Regarding Size, Share & Growth Oppo …
New Research Study Tattoo Accessories Market 2024 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook has been added to Coherent Market insight The Tattoo Accessories Market research report provides an analysis of major manufacturers, and geographic regions, and provides advanced information about the major challenges that will affect market growth. The report includes definition, classification, application and industrial chain structure, development trend, analysis
Adhesive Films Market Size and Share 2024-2031 Detailed Analysis by Company Profiles and Market Development Status |BASF SE, 3M, Ashland Inc., H.B. Fuller Company
Adhesive Films Market Size and Share 2024-2031 Detailed Analysis by Company Prof …
Global adhesive films market is projected to reach around US$ 25.37 Bn by 2030, in terms of revenue, exhibiting a CAGR of 5.8% during the forecast period (2023-2030). New Research Study Adhesive Films Market 2024 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook has been added to Coherent Market insight The Adhesive Films Market research report provides an analysis of major manufacturers, and geographic
Safety Knives Market Demand Increasing and Industry Analysis in Upcoming Years by 2024-2031 |   Martor KG, Slice, Inc., The Safety Knife Company
Safety Knives Market Demand Increasing and Industry Analysis in Upcoming Years b …
New Research Study Safety Knives Market 2024 Analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share, and Outlook has been added to Coherent Market insight The Safety Knives Market research report provides an analysis of major manufacturers, and geographic regions, and provides advanced information about the major challenges that will affect market growth. The report includes definition, classification, application and industrial chain structure, development trend, analysis

All 5 Releases


More Releases for CNS

Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and
CNS Therapeutics Technology Forecast Research Report 2018-2025
The Global CNS Therapeutics Market 2018-2028 report offers a detailed analysis of the industry, with market size forecasts covering the next ten years. This report will also analyze factors that influence demand for tactical communication, key market trends, and challenges faced by industry participants. The CNS Therapeutics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With the
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the
Central Nervous System (CNS) Biomarkers Market - World is Witnessing a Rapid Gro …
Biomarkers are used to indicate the biological state of a process, pathogenic process or therapeutic action. Biomarkers facilitate understanding the development of a chronic disease, relationship between exposure to environmental chemicals and identification of subgroups of people who are relatively at high risk of developing disease. Download Exclusive Sample of this Report: http://bit.ly/2fOOwAv Continued development in related technologies such as genomics, proteomics and imaging system has accelerated the development of biomarkers.
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575 Notes: Production, means the output of CNS Therapeutics Revenue, means the sales value of CNS Therapeutics This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Pfizer, Inc. (USA) Johnson & Johnson (USA) Bristol-Myers Squibb